Cough Drops Creamy Strawberry shortage — US supply status & alternatives

Cough Drops Creamy Strawberry

—

In supply · Australia

Quality Choice Cough Drops Creamy Strawberry

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Cough Drops Creamy Strawberry
Brand names	Quality Choice Cough Drops Creamy Strawberry

Therapeutic category	Auto-created by FDA Drug Enforcement — Foreign Manufacturer Recalls scraper

Controlled substance	No

Marketing-authorisation holders	7-ELEVEN, CHAIN DRUG MARKETING ASSOCIATION, INC.

Registrations on file	2

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
Menthol Cough Drops Creamy Strawberry Flavor	2.5; 7mg/1; mg/1	lozenge	🇺🇸 US	7-ELEVEN	Active
QUALITY CHOICE Cough Drops Creamy Strawberry	2.5; 7mg/1; mg/1	lozenge	🇺🇸 US	CHAIN DRUG MARKETING ASSOCIATION, INC.	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.